1. Home
  2. Medical Devices & Consumables
  3. Global Atrial Fibrillation Market By Product Type, By End User By Application And By Region (Global Market Forecast To 2025)

Global Atrial Fibrillation Market By Product Type, By End User By Application And By Region (Global Market Forecast To 2025)

Publication Month: Feb 2020 | No. of Pages: 128 Published By: Reports Intellect
Single User License: US $ 3500
Corporate User License: US $ 6500

The Global Atrial fibrillation market is estimated to reach $ 15.2 billion by 2025 from $ 6.4 billion in 2017; growing at a CAGR of 12.2% from 2019 to 2025.

Arrhythmia means irregular heartbeat. Irregular heartbeat is either too slow (bradycardia) or too fast (tachycardia).

Types of arrhythmias

  • Atrial fibrillation
  • Premature atrial contractions
  • Premature ventricular contractions
  • Atrial flutter
  • Paroxysmal supraventricular tachycardia
  • Accessory pathway tachycardia
  • AV nodal re-entrant tachycardia
  • Ventricular tachycardia
  • Ventricular fibrillation
  • Long QT syndrome
  • Bradyarrhythmias
  • Sinus node dysfunction
  • etc

In atrial fibrillation, the upper chamber of the heart (i.e. atria) beats in an irregular pattern, results in stroke and cardiovascular diseases.

Market Dynamics

The Global Atrial fibrillation market is primarily driven by factors such as the increasing population of patient with cardiovascular diseases, improvement in healthcare facilities, technological advancement, research and developments, increasing geriatric population, increasing prevalence of hypertension, obesity, diabetes, etc. are some of the forces, which drive the market.

Market Segmentation

The Global Atrial fibrillation market is mainly classified based on product type, by end-user, by application, and by region.

Based on the Product Type segment, the market is categorized into cardiac monitors, EP ablation catheters, EP diagnostic catheters, access devices, EP mapping, and recording systems, LAA closure, and others. Among them, an EP ablation catheter has dominated the market.

Based on the End User, the market is further segmented into hospitals, surgical centers, and electrophysiology labs. Among them, hospitals have dominated the market.

Based on the Application, the market is further segmented into surgical, diagnostic, and EP ablation. Among them, EP ablation has dominated the market.

Regional Analysis

Based on geography, the global Atrial fibrillation market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

Among all the regions, Europe has generated the highest revenue. This is due to technological advancement and growing healthcare infrastructure.

Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Competitive Landscape

Key players operating in the Atrial fibrillation market include Johnson & Johnson, Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, biotronik, MicroPort Scientific Corporation, Koninklijke Philips N.V., AtriCure Inc., CardioFocus Inc., Osypka AG, other players.

Atrial Fibrillation Market Key Segments:

By Product Type

  • Cardiac Monitors
  • Access Devices
  • EP ablation Catheters
  • EP Diagnostic Catheters
  • EP Mapping & Recording Systems
  • LAA Closure
  • Others

By End-User

  • Hospitals
  • Surgical Centers
  • Electrophysiology Labs

By Application

  • Surgical
  • Diagnostic
  • EP ablation

By Region

  • North America
  • The U.S.A
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Egypt
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

 

1 Market Overview

1.1 Atrial fibrillation Introduction

1.2 Market Analysis by Product Type

1.2.1 Overview: Global Atrial fibrillation Revenue by Product Type: 2017 VS 2019 VS 2025

1.2.2 Cardiac Monitors

1.2.3 Access Devices

1.2.4 EP Ablation Catheters

1.2.5 EP Diagnostic Catheters

1.2.6 EP Mapping & Recording Systems

1.2.7 LAA Closure

1.2.8 Others

1.3 Market Analysis by End User

1.3.1 Overview: Global Atrial fibrillation Revenue by End User: 2017 VS 2019 VS 2025

1.3.2 Hospitals

1.3.3 Surgical Centers

1.3.4 Electrophysiology Labs

1.4 Market Analysis by Application

1.4.1 Overview: Global Atrial fibrillation Revenue by Application: 2017 VS 2019 VS 2025

1.4.2 Surgical

1.4.3 Diagnostic

1.4.4 EP Ablation

1.5 Overview of Global Atrial fibrillation Market

1.5.1 Global Atrial fibrillation Market Status and Outlook (2017-2025)

1.5.2 North America (United States, Canada and Mexico)

1.5.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.5.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.5.5 South America, Middle East & Africa

1.6 Market Dynamics

1.6.1 Market Opportunities

1.6.2 Market Risk

1.6.3 Market Driving Force

2 Manufacturers Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Abbott Laboratories SWOT Analysis

2.1.4 Abbott Laboratories Product and Services

2.1.5 Abbott Laboratories Atrial fibrillation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.2 Johnson & Johnson

2.2.1 Johnson & Johnson Details

2.2.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Johnson & Johnson SWOT Analysis

2.2.4 Johnson & Johnson Product and Services

2.2.5 Johnson & Johnson Atrial fibrillation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.3 Medtronic Plc

2.3.1 Medtronic Plc Details

2.3.2 Medtronic Plc Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Medtronic Plc SWOT Analysis

2.3.4 Medtronic Plc Product and Services

2.3.5 Medtronic Plc Atrial fibrillation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.4 Boston Scientific Corporation

2.4.1 Boston Scientific Corporation Details

2.4.2 Boston Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Boston Scientific Corporation SWOT Analysis

2.4.4 Boston Scientific Corporation Product and Services

2.4.5 Boston Scientific Corporation Atrial fibrillation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.5 MicroPort Scientific Corporation

2.5.1 MicroPort Scientific Corporation Details

2.5.2 MicroPort Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 MicroPort Scientific Corporation SWOT Analysis

2.5.4 MicroPort Scientific Corporation Product and Services

2.5.5 MicroPort Scientific Corporation Atrial fibrillation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.6 Biotronik

2.6.1 Biotronik Details

2.6.2 Biotronik Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Biotronik SWOT Analysis

2.6.4 Biotronik Product and Services

2.6.5 Biotronik Atrial fibrillation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.7 Koninklijke Philips N.V.

2.7.1 Koninklijke Philips N.V.

2.7.2 Koninklijke Philips N.V. Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Koninklijke Philips N.V. SWOT Analysis

2.7.4 Koninklijke Philips N.V. Product and Services

2.7.5 Koninklijke Philips N.V. Atrial fibrillation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.8 AtricCure Inc.

2.8.1 AtricCure Inc. Details

2.8.2 AtricCure Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 AtricCure Inc. SWOT Analysis

2.8.4 AtricCure Inc. Product and Services

2.8.5 AtricCure Inc. Atrial fibrillation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.9 CardioFocus Inc.

2.9.1 CardioFocus Inc. Details

2.9.2 CardioFocus Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 CardioFocus Inc. SWOT Analysis

2.9.4 CardioFocus Inc. Product and Services

2.9.5 CardioFocus Inc. Atrial fibrillation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020)

2.10 Osypka AG

2.10.1 Osypka AG

2.10.2 Osypka AG Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Osypka AG SWOT Analysis

2.10.4 Osypka AG Product and Services

2.10.5 Osypka AG Atrial fibrillation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019-2020) 3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Atrial fibrillation Sales and Market Share by Manufacturer (2018-2019-2020)

3.2 Global Atrial fibrillation Revenue and Market Share by Manufacturer (2018-2019-2020)

3.3 Market Concentration Rate

3.3.1 Top 3 Atrial fibrillation Manufacturer Market Share in 2019 & 2020

3.3.2 Top 6 Atrial fibrillation Manufacturer Market Share in 2019 & 2020

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Atrial fibrillation Sales, Revenue and Market Share by Regions

4.1.1 Global Atrial fibrillation Sales and Market Share by Regions (2017-2020)

4.1.2 Global Atrial fibrillation Revenue and Market Share by Regions (2017-2020)

4.2 North America Atrial fibrillation Sales and Growth Rate (2017-2020)

4.3 Europe Atrial fibrillation Sales and Growth Rate (2017-2020)

4.4 Asia-Pacific Atrial fibrillation Sales and Growth Rate (2017-2020)

4.5 South America Atrial fibrillation Sales and Growth Rate (2017-2020)

4.6 Middle East and Africa Atrial fibrillation Sales and Growth Rate (2017-2020)

5 North America by Country

5.1 North America Atrial fibrillation Sales, Revenue and Market Share by Country

5.1.1 North America Atrial fibrillation Sales and Market Share by Country (2017-2020)

5.1.2 North America Atrial fibrillation Revenue and Market Share by Country (2017-2020)

5.2 United States Atrial fibrillation Sales and Growth Rate (2017-2020)

5.3 Canada Atrial fibrillation Sales and Growth Rate (2017-2020)

5.4 Mexico Atrial fibrillation Sales and Growth Rate (2017-2020)

6 Europe by Country

6.1 Europe Atrial fibrillation Sales, Revenue and Market Share by Country

6.1.1 Europe Atrial fibrillation Sales and Market Share by Country (2017-2020)

6.1.2 Europe Atrial fibrillation Revenue and Market Share by Country (2017-2020)

6.2 Germany Atrial fibrillation Sales and Growth Rate (2017-2020)

6.3 UK Atrial fibrillation Sales and Growth Rate (2017-2020)

6.4 France Atrial fibrillation Sales and Growth Rate (2017-2020)

6.5 Russia Atrial fibrillation Sales and Growth Rate (2017-2020)

6.6 Italy Atrial fibrillation Sales and Growth Rate (2017-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Atrial fibrillation Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Atrial fibrillation Sales and Market Share by Regions (2017-2020)

7.1.2 Asia-Pacific Atrial fibrillation Revenue and Market Share by Regions (2017-2020)

7.2 China Atrial fibrillation Sales and Growth Rate (2017-2020)

7.3 Japan Atrial fibrillation Sales and Growth Rate (2017-2020)

7.4 Korea Atrial fibrillation Sales and Growth Rate (2017-2020)

7.5 India Atrial fibrillation Sales and Growth Rate (2017-2020)

7.6 Southeast Asia Atrial fibrillation Sales and Growth Rate (2017-2020)

7.7 Australia Atrial fibrillation Sales and Growth Rate (2017-2020)

8 South America by Country

8.1 South America Atrial fibrillation Sales, Revenue and Market Share by Country

8.1.1 South America Atrial fibrillation Sales and Market Share by Country (2017-2020)

8.1.2 South America Atrial fibrillation Revenue and Market Share by Country (2017-2020)

8.2 Brazil Atrial fibrillation Sales and Growth Rate (2017-2020)

8.3 Argentina Atrial fibrillation Sales and Growth Rate (2017-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Atrial fibrillation Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Atrial fibrillation Sales and Market Share by Country (2017-2020)

9.1.2 Middle East & Africa Atrial fibrillation Revenue and Market Share by Country (2017-2020)

9.2 Saudi Arabia Atrial fibrillation Sales and Growth Rate (2017-2020)

9.3 Turkey Atrial fibrillation Sales and Growth Rate (2017-2020)

9.4 Egypt Atrial fibrillation Sales and Growth Rate (2017-2020)

9.5 South Africa Atrial fibrillation Sales and Growth Rate (2017-2020)

10 Market Segment by Product Type

10.1 Global Atrial fibrillation Sales and Market Share by Product Type (2017-2020)

10.2 Global Atrial fibrillation Revenue and Market Share by Product Type (2017-2020)

10.3 Global Atrial fibrillation Price by Product Type (2017-2020)

11 Global Atrial fibrillation Market Segment by End User

11.1 Global Atrial fibrillation Sales Market Share by End User (2017-2020)

11.2 Global Atrial fibrillation Revenue Market Share by End User (2017-2020)

11.3 Global Atrial fibrillation Price by End User (2017-2020)

12 Global Atrial fibrillation Market Segment by Application

12.1 Global Atrial fibrillation Sales Market Share by Application (2017-2020)

12.2 Global Atrial fibrillation Revenue Market Share by Application (2017-2020)

12.3 Global Atrial fibrillation Price by Application (2017-2020)

13 Market Forecast

13.1 Global Atrial fibrillation Sales, Revenue and Growth Rate (2021-2025)

13.2 Atrial fibrillation Market Forecast by Regions (2021-2025)

13.2.1 North America Atrial fibrillation Market Forecast (2021-2025)

13.2.2 Europe Atrial fibrillation Market Forecast (2021-2025)

13.2.3 Asia-Pacific Atrial fibrillation Market Forecast (2021-2025)

13.2.4 South America Atrial fibrillation Market Forecast (2021-2025)

13.2.5 Middle East & Africa Atrial fibrillation Market Forecast (2021-2025)

13.3 Atrial fibrillation Market Forecast by Product Type (2021-2025)

13.3.1 Global Atrial fibrillation Sales Forecast by Product Type (2021-2025)

13.3.2 Global Atrial fibrillation Market Share Forecast by Product Type (2021-2025)

13.5 Atrial fibrillation Market Forecast by End User (2021-2025)

13.5.1 Global Atrial fibrillation Sales Forecast by End User (2021-2025)

13.5.2 Global Atrial fibrillation Market Share Forecast by End User (2021-2025) 13.6 Atrial fibrillation Market Forecast by Application (2021-2025)

13.6.1 Global Atrial fibrillation Sales Forecast by Application (2021-2025)

13.6.2 Global Atrial fibrillation Market Share Forecast by Application (2021-2025)

14 Sales Channel, Distributors, Traders and Dealers

14.1 Sales Channel

14.1.1 Direct Marketing

14.1.2 Indirect Marketing

14.2 Distributors, Traders and Dealers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology

16.2 Data Source

16.3 Disclaimer

16.4 About US

 

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets